Insulet Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Wedbush Raises Price Target on Insulet (PODD) to $48 Following 2Q Beat
August 4, 2016 10:01 AM EDTWedbush reiterated an Outperform rating on Insulet Corporation (NASDAQ: PODD), and raised the price target to $48.00 (from $44.00), following the company's 2Q earnings report. Revenues of $87 million were $4 million ahead of consensus. EPS of ($0.07) was 10c better than consensus.
Analyst Tao Levy commented,... More
Leerink Partners Raises Price Target on Insulet (PODD) to $50; Reiterates Outperform
August 4, 2016 7:24 AM EDTLeerink Partners reiterated an Outperform rating on Insulet Corporation (NASDAQ: PODD), and raised the price target to $50.00 (from $40.00), following the company's 2Q earnings report.
Analyst Danielle Antalffy commented, "Another strong quarter of outperformance supports our recent view that PODD is... More
Insulet Corporation (PODD) PT Raised to $46 at Piper Jaffray
August 4, 2016 6:52 AM EDTPiper Jaffray analyst Brooks West reiterated an Overweight rating and raised his price target on Insulet Corporation (NASDAQ: PODD) to $46.00 (from $41.00) following strong Q2 results.
West commented, "Insulet posted 2Q16 revenues of $87.3M (+44% proforma), 5%+ above the consensus estimate of $83.0M, primarily on strength in... More
Insulet (PODD) Tops Q2 EPS by 9c, Lifts Revenue Guidance
August 3, 2016 4:04 PM EDTInsulet (NASDAQ: PODD) reported Q2 EPS of ($0.08), $0.09 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $87.3 million versus the consensus estimate of $81.1 million.
GUIDANCE:
Insulet sees Q3 2016 revenue of $88-91 million, versus the consensus of $87... More
